These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38028196)

  • 1. Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model.
    Xiao H; Amarsaikhan O; Zhao Y; Yu X; Hu X; Han S; Chaolumen ; Baigude H
    Mol Ther Nucleic Acids; 2023 Dec; 34():102065. PubMed ID: 38028196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Lipidated Ligands and Formulation of Glia-Specific LNPs for RNAi-Mediated BBB Protection.
    Xiao H; Bao X; Bai N; Zhu W; Saqirila S; Hu X; Bao Q; Baigude H
    J Med Chem; 2024 Aug; 67(15):13217-13230. PubMed ID: 39031092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury.
    Waggoner LE; Miyasaki KF; Kwon EJ
    Biomater Sci; 2023 Jun; 11(12):4238-4253. PubMed ID: 36987922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetic Lipid-Nanoparticle-Mediated Knockdown of TLR4 in CNS Protects against Cerebral Ischemia/Reperfusion Injury in Mice.
    Ganbold T; Bao Q; Xiao H; Zurgaanjin D; Liu C; Han S; Hasi A; Baigude H
    Nanomaterials (Basel); 2022 Jun; 12(12):. PubMed ID: 35745411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury.
    Zhang H; Ding F; Zhu Z; Sun Q; Yang C
    Int J Pharm; 2023 Jan; 631():122489. PubMed ID: 36521639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
    Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
    Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.
    Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T
    Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles.
    Mo Y; Cheng MHY; D'Elia A; Doran K; Ding L; Chen J; Cullis PR; Zheng G
    ACS Nano; 2023 Mar; 17(5):4688-4703. PubMed ID: 36853331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the siRNA knockdown efficiency of lipid nanoparticles by morphological transformation with the use of dihydrosphingomyelin as a helper lipid.
    Hashimoto M; Yonezawa S; Furan S; Nitta C; Maeda N; Tomita K; Yokouchi A; Koide H; Asai T
    Biomater Sci; 2023 May; 11(9):3269-3277. PubMed ID: 36939181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
    Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
    Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.
    Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR
    Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kawase W; Kurotaki D; Suzuki Y; Ishihara H; Ban T; Sato GR; Ichikawa J; Yanai H; Taniguchi T; Tsukahara K; Tamura T
    Mol Ther Nucleic Acids; 2021 Sep; 25():708-715. PubMed ID: 34589288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular-Level Structural Analysis of siRNA-Loaded Lipid Nanoparticles by
    Ueda K; Sakagawa Y; Saito T; Fujimoto T; Nakamura M; Sakuma F; Kaneko S; Tokumoto T; Nishimura K; Takeda J; Arai Y; Yamamoto K; Ikeda Y; Higashi K; Moribe K
    Mol Pharm; 2023 Sep; 20(9):4729-4742. PubMed ID: 37606988
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids.
    Ehexige E; Ganbold T; Yu X; Han S; Baigude H
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31546908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.
    Evers MJW; Du W; Yang Q; Kooijmans SAA; Vink A; van Steenbergen M; Vader P; de Jager SCA; Fuchs SA; Mastrobattista E; Sluijter JPG; Lei Z; Schiffelers R
    J Control Release; 2022 Mar; 343():207-216. PubMed ID: 35077739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.